Ana Kollcaku

Ana brings a wealth of management consulting experience, most recently with EY. She has been responsible for strategic & execution projects, including health initiatives for Pfizer, Artsana & Sivantos.

Hajime Sato

Hajime leads our relationship with Japanese corporates and investors. With a background as entrepreneur & investor, Hajime connects health innovators & business to drive transformation.

Sara Schmachtenberg

With a deep conviction that digital health strategy should be based on facts, not hype, Sara leads the data and analytics insights of Galen Growth in the USA and Europe.  With 10 years of medical device experience across both corporate and startups, Sara brings a wealth of experience to our client base.

Kellerine Quah

Kellerine supports the Galen Growth team in developing key insights into digital health. Her previous experiences range from communications in a health non-profit organization to leading a gospel choir. Kellerine graduated from University College London with a BSc in Biomedical Sciences.

Jeffrey Teo

Graduating with an Information Systems degree, Jeffrey believes that data is the sun, harnessing limitless power and impacting all areas of a business. He supports Galen Growth with developing new insights and maintaining data quality.

Ya Min Thu

Ya Min supports Galen Growth with insights into HealthTech data and analytics. Her understanding of machine learning algorithms and practices help the company tackle the challenges at hand.

Lawrence Wurtz

Lawrence leads Galen Growths efforts in North American, with over 20 years of Operations and Sales experience in healthcare. He is experienced in high-growth healthcare technology companies and possesses a deep understanding of digital health startups. Lawrence’s previous experiences range from co-founder of a healthcare technology and services company, being a part of organizations such as LabCorp, Allscripts, and Scribe.

Marcus Goh

Dr Snehal Patel

Dr Patel co-founded MyDoc and is also a Managing Director of Saena Partners, a Singapore-based investment company. Previously, he was a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. His responsibilities included leading the on-the-ground incubation and early growth of a regional healthcare chain, as well as serving on the boards of several early-stage healthcare and education businesses throughout the region.

Prior to moving to Singapore in 2008, Dr Patel practiced law at Cravath, Swaine & Moore, and LLP in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright scholarship to study the differences between the Singaporean and US healthcare systems. Dr Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows.

More about Dr Snehal Patel

• Clinical Fellow at Harvard Medical School
• Featured speaker at 2011 Milken Global Conference

Rosaline Chow Koo

Rosaline invested $5M of her savings and borrowed another $5M to build CXA after 5 years trying to convince her previous firm to invest in Asia. Now CXA has 800k users across 20 countries in Asia is being white-labelled as the SME bancassurance platform for many banks. CXA has been awarded Insurtech of the Year, Top CEO, Global Innovations in Healthcare, Asian Human Capital Leadership Award, Asian Insurance Innovations and HR Vendor of the Year for Corp Wellness and Comp & Benefits.
 
Rosaline supervised Procter & Gamble factory lines in Iowa and then worked at Bankers Trust on Wall Street. She launched two dot-com start-ups before moving to ACE insurance. Rosaline also grew Mercer Marsh Benefits’ 14 APAC countries 800% over 8 years. She graduated from UCLA Cybernetics and Columbia Business School. 

Gavin Teo

Gavin Teo is a General Partner at Altara Ventures where he focuses on early stage investments in Southeast Asia technology. He was previously a General Partner at B Capital Group, a global venture growth fund where he led the investment committee and managed investments in digital health and consumer internet. Earlier in his career, Gavin was an investor at Comcast Ventures, a product manager at Zynga and a management consultant at Bain & Company. Gavin earned his M.B.A. from The Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar, and holds a B.A. in Economics from Claremont McKenna College. 

Charles Toomey

An Asian Healthcare Industry expert with over 20 years experience leading and building businesses across the Asia Pacific region. Currently, Charles uses his expertise and industry knowledge to help healthcare start-ups through investment and growth accelerating their development through application of his leadership capability and leveraging his network. In 2015, Charles co-founded Action4Diabetics, a U.K. registered charity focused on tackling Type 1 Diabetes across SE Asia. 

Nawal Roy

Nawal is the Founder and CEO of Holmusk – a global digital health platform pioneering in new approaches of looking at long-term illnesses.

Over the years, Nawal has been deeply involved with serving clients across North American, Europe, South East Asia, India, China, Middle East & Africa.

Prior to this, Nawal was the Co-Founder and CEO of HelloPay (Rocket internet venture). Before leading HelloPay, he was a Junior Partner leading client advisory service line in McKinsey & Company. Before Mckinsey, Nawal was the Managing Partner of Shobhit Capital Group, an independent advisory and capital investment firm. Prior to Shobhit Capital, Nawal was a risk management specialist leading ERM initiative at Moody’s Investor Services.

Nawal is one of the founders of PRMIA where he was one of the Directors of Board of PRMIA and Regional Director of the New York Chapter. He has also worked at KPMG, Credit Suisse First Boston and Deutsche Bank.

More about Nawal Roy

• Co-founder, PRMIA
• Founder & CEO, HelloPay

Dr Ronald Ling

Dr Ling is the Founder and Managing Director of Sanus Advisory Asia, an independent advisory firm in Singapore that provides investment and transaction-related services across Asia within the healthcare industry.

A veteran of healthcare investing in Asia with over 20 years experience in consulting, operations and private equity roles, Dr Ling is also Director and Advisor to Connected Health, a Singapore-based remote monitoring and disease management company, and an occasional angel investor. Prior to setting up Sanus Asia, Dr Ling was Managing Director of Pricewaterhouse Cooper’s Healthcare practice and the firm’s Asia Healthcare Leader.

Dr Ling was previously a partner with Symphony Asia (formerly Schroder Capital Partners); a mid-sized private equity firm based in Singapore. At Symphony Dr Ling led healthcare deals and held Board appointments with Parkway Holdings (Asia’s largest private healthcare services company) and Strides Arcolab (a mid-tier listed Indian generic pharmaceutical company), among others

Dr Snehal Patel

Dr Patel co-founded MyDoc and is also a Managing Director of Saena Partners, a Singapore-based investment company. Previously, he was a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. His responsibilities included leading the on-the-ground incubation and early growth of a regional healthcare chain, as well as serving on the boards of several early-stage healthcare and education businesses throughout the region.

Prior to moving to Singapore in 2008, Dr Patel practiced law at Cravath, Swaine & Moore, and LLP in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright scholarship to study the differences between the Singaporean and US healthcare systems. Dr Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows.

More about Dr Snehal Patel

• Clinical Fellow at Harvard Medical School
• Featured speaker at 2011 Milken Global Conference

Jeremy Sun

Jeremy Sun is the Design Director of Orcadesign Consultants, a forward-thinking innovation and strategy consultancy firm with studios in Singapore and Malaysia. An innovation designer with over 20 years of rich experience, Jeremy has lent his expertise to start-ups, SMEs, global brands and government agencies. He works closely with his clients to reframe challenges, create compelling visions and develop business strategies. Jeremy also advocates a user-centred innovation approach and designs impactful and insightful solutions that resonate with his clients’ target markets.

An avid design educator, Jeremy also conducts collaborative workshops to build innovation capabilities amongst diverse groups and organisations. He is also active in design education and promotion, having lectured in undergraduate programs in design institutions and forums.

Recognised as an industry leader, Jeremy has also been invited to serve as jury for international awards such as iF Award. In addition, Jeremy and his team have received numerous accolades, including the President’s Design Award Singapore, Universal Design Award, IDEA Award and Geneva Innovation Awards.

More about Jeremy Sun

• Published Empathetic Technology for Ageing – Rethinking Health and Wellness for the Elderly in Singapore: Infocomm Technology Sector
• Diverse portfolio of clientele including Samsung, Sony, Hewlett-Packard, Rentokil Initial, Welch Allyn, OSIM etc
• 15 years of experience in design education in Nanyang Polytechnic (NYP), Nanyang Technological University (NTU) and National University of Singapore (NUS)

Future4Care

Future4care is a unique open-innovation ecosystem in Europe. It is both a startup accelerator and an Institute providing content on digital health and delivering reference certifications. The Institute is a genuine knowledge centre offering conference programs, conducting constant monitoring of new technologies and their use and connecting members of its community with external experts.

HIMSS

HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and digital health transformation to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our innovation engine delivers key insights, education and engaging events to healthcare providers, payers, governments, startups, life sciences and other health services organizations, ensuring they have the right information at the point of decision.

HIMSS has served the global health community for more than 60 years, with focused operations across North America, Europe, the United Kingdom, the Middle East and Asia-Pacific.

HLTH

HLTH is a community of leaders, innovators, and pioneers of the health industry and span across the entire health ecosystem; payers, providers, employers, investors, startups, life sciences, policymakers, and the patient community to discuss the trends and strategies needed to create health’s future.

FINN Partners

Founded in 2011 on the core principles of innovation and collaborative partnership, FINN Partners has grown from about $24 million in fees to almost $200 million in fees during the past 10 years, becoming one of the fastest-growing independent public relations agencies in the world and recognized as a PRovoke Media 2022 Agency of the Year. The full-service marketing and communications company’s record-setting pace results from organic growth and integrating new companies and new people into the FINN world through a common philosophy. With more than 1,300 professionals across 33 offices, FINN provides clients with global access and capabilities in the Americas, Europe and Asia. In addition, FINN provides its clients with access to top-tier agencies worldwide through its membership in the global network PROI.

Headquartered in New York, FINN has offices in: Atlanta, Bangalore, Beijing, Boston, Chicago, Delhi, Denver, Detroit, Dublin, Fort Lauderdale, Frankfurt, Guam, Hong Kong, Honolulu, Jerusalem, Kuala Lumpur, London, Los Angeles, Manila, Mumbai, Munich, Nashville, Orange County, Paris, Portland, San Diego, San Francisco, Seattle, Shanghai, Singapore, Vancouver and Washington D.C.